The miasma hangs heavy over the rising reports of liver injury in patients consuming weight-loss medications like orlistat, vended under the name of prescription medicine Xenical and the past-the-counter drug Alli. FDA has recently made an announcement regarding the detailed scrutiny of the thirty-two undesirable episodes of grave liver damage in those consuming orlistat that were observed during the time periods of 1999-2008, inclusive of twenty-seven cases that needed to be hospitalized and six of them with liver breakdown reported. FDA has made a notable finding that nearly thirty of the reported cases transpired outside the United States. Xenical received FDA approval in 1999 while Alli got granted approval in 2007 as above-the-counter weight loss means for adult usage. Xenical is sold in close to hundred countries following approval. The widespread cited unpleasant episodes comprised of yellowing of skin or in the white portion of the eyes –jaundice, feeling a sense of being  [...]